Report cover image

Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Sep 29, 2025
Length 150 Pages
SKU # GV20471166

Description

Research Antibodies Market Summary

The global research antibodies market size was estimated at USD 1.79 billion in 2024 and is projected to reach USD 3.91 billion by 2033, growing at a CAGR of 9.15% from 2025 to 2033. The market for research antibodies is expanding rapidly due to the rising incidence of infectious and chronic illnesses, improvements in proteomics and genomics research, and the growing use of personalized medicine.

Global Research Antibodies Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global research antibodies market report based on product, specificity, technology, source, application, end use, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Primary Antibodies
  • Secondary Antibodies
  • Specificity Outlook (Revenue, USD Million, 2021 - 2033)
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunohistochemistry
  • Immunofluorescence
  • Western Blotting
  • Flow Cytometry
  • Immunoprecipitation
  • ELISA
  • Others
  • Source Outlook (Revenue, USD Million, 2021 - 2033)
  • Mouse
  • Rabbit
  • Goat
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Infectious Diseases
  • Immunology
  • Oncology
  • Stem Cells
  • Neurobiology
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Singapore
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Segment
1.1.2. Specificity Segment
1.1.3. Technology Segment
1.1.4. Source Segment
1.1.5. Application Segment
1.1.6. End Use Segment
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List Of Secondary Sources
1.8. List Of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising burden of chronic and infectious diseases
3.2.1.2. Expansion of life sciences and biomedical research
3.2.2. Market Restraint And Challenges Analysis
3.2.2.1. Uncertain government regulations
3.2.2.2. Quality concerns associated with research antibodies and the time- & cost-intensive process of antibody development
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Research Antibodies Market Product Movement Analysis
4.3. Research Antibodies Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Primary Antibodies
4.4.1. Primary Antibodies Market, 2021 - 2033 (USD Million)
4.5. Secondary Antibodies
4.5.1. Secondary Antibodies Market, 2021 - 2033 (USD Million)
Chapter 5. Specificity Business Analysis
5.1. Specificity Segment Dashboard
5.2. Research Antibodies Market Specificity Movement Analysis
5.3. Research Antibodies Market Size & Trend Analysis, by Specificity, 2021 to 2033 (USD Million)
5.4. Monoclonal Antibodies
5.4.1. Monoclonal Antibodies Market, 2021 - 2033 (USD Million)
5.5. Polyclonal Antibodies
5.5.1. Polyclonal Antibodies Market, 2021 - 2033 (USD Million)
Chapter 6. Technology Business Analysis
6.1. Technology Segment Dashboard
6.2. Research Antibodies Market Technology Movement Analysis
6.3. Research Antibodies Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. Immunohistochemistry
6.4.1. Immunohistochemistry Market, 2021 - 2033 (USD Million)
6.5. Immunofluorescence
6.5.1. Immunofluorescence Market, 2021 - 2033 (USD Million)
6.6. Western Blotting
6.6.1. Western Blotting Market, 2021 - 2033 (USD Million)
6.7. Flow Cytometry
6.7.1. Flow Cytometry Market, 2021 - 2033 (USD Million)
6.8. Immunoprecipitation
6.8.1. Immunoprecipitation Market, 2021 - 2033 (USD Million)
6.9. ELISA
6.9.1. ELISA Market, 2021 - 2033 (USD Million)
6.10. Others
6.10.1. Other Technologies Market, 2021 - 2033 (USD Million)
Chapter 7. Source Business Analysis
7.1. Source Segment Dashboard
7.2. Research Antibodies Market Source Movement Analysis
7.3. Research Antibodies Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
7.4. Mouse
7.4.1. Mouse Market, 2021 - 2033 (USD Million)
7.5. Rabbit
7.5.1. Rabbit Market, 2021 - 2033 (USD Million)
7.6. Goat
7.6.1. Goat Market, 2021 - 2033 (USD Million)
7.7. Others
7.7.1. Other Sources Market, 2021 - 2033 (USD Million)
Chapter 8. Application Business Analysis
8.1. Application Segment Dashboard
8.2. Research Antibodies Market Application Movement Analysis
8.3. Research Antibodies Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
8.4. Infectious Diseases
8.4.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
8.5. Immunology
8.5.1. Immunology Market, 2021 - 2033 (USD Million)
8.6. Oncology
8.6.1. Oncology Market, 2021 - 2033 (USD Million)
8.7. Stem Cells
8.7.1. Stem Cells Market, 2021 - 2033 (USD Million)
8.8. Neurobiology
8.8.1. Neurobiology Market, 2021 - 2033 (USD Million)
8.9. Others
8.9.1. Other Applications Market, 2021 - 2033 (USD Million)
Chapter 9. End Use Business Analysis
9.1. End Use Segment Dashboard
9.2. Research Antibodies Market End Use Movement Analysis
9.3. Research Antibodies Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Academic & Research Institutes
9.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
9.5. Contract Research Organizations
9.5.1. Contract Research Organizations Market, 2021 - 2033 (USD Million)
9.6. Pharmaceutical & Biotechnology Companies
9.6.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
Chapter 10. Regional Business Analysis
10.1. Research Antibodies Market Share By Region, 2024 & 2033
10.2. North America
10.2.1. North America Research Antibodies Market, 2021 - 2033 (USD Million)
10.2.2. U.S.
10.2.2.1. Key Country Dynamics
10.2.2.2. Regulatory Framework
10.2.2.3. Competitive Scenario
10.2.2.4. U.S. Research Antibodies Market, 2021 - 2033 (USD Million)
10.2.3. Canada
10.2.3.1. Key Country Dynamics
10.2.3.2. Regulatory Framework
10.2.3.3. Competitive Scenario
10.2.3.4. Canada Research Antibodies Market, 2021 - 2033 (USD Million)
10.2.4. Mexico
10.2.4.1. Key Country Dynamics
10.2.4.2. Regulatory Framework
10.2.4.3. Competitive Scenario
10.2.4.4. Mexico Research Antibodies Market, 2021 - 2033 (USD Million)
10.3. Europe
10.3.1. Europe Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.2. UK
10.3.2.1. Key Country Dynamics
10.3.2.2. Regulatory Framework
10.3.2.3. Competitive Scenario
10.3.2.4. UK Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.3. Germany
10.3.3.1. Key Country Dynamics
10.3.3.2. Regulatory Framework
10.3.3.3. Competitive Scenario
10.3.3.4. Germany Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.4. France
10.3.4.1. Key Country Dynamics
10.3.4.2. Regulatory Framework
10.3.4.3. Competitive Scenario
10.3.4.4. France Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.5. Italy
10.3.5.1. Key Country Dynamics
10.3.5.2. Regulatory Framework
10.3.5.3. Competitive Scenario
10.3.5.4. Italy Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.6. Spain
10.3.6.1. Key Country Dynamics
10.3.6.2. Regulatory Framework
10.3.6.3. Competitive Scenario
10.3.6.4. Spain Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.7. Denmark
10.3.7.1. Key Country Dynamics
10.3.7.2. Regulatory Framework
10.3.7.3. Competitive Scenario
10.3.7.4. Denmark Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.8. Sweden
10.3.8.1. Key Country Dynamics
10.3.8.2. Regulatory Framework
10.3.8.3. Competitive Scenario
10.3.8.4. Sweden Research Antibodies Market, 2021 - 2033 (USD Million)
10.3.9. Norway
10.3.9.1. Key Country Dynamics
10.3.9.2. Regulatory Framework
10.3.9.3. Competitive Scenario
10.3.9.4. Norway Research Antibodies Market, 2021 - 2033 (USD Million)
10.4. Asia Pacific
10.4.1. Asia Pacific Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.2. Japan
10.4.2.1. Key Country Dynamics
10.4.2.2. Regulatory Framework
10.4.2.3. Competitive Scenario
10.4.2.4. Japan Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.3. China
10.4.3.1. Key Country Dynamics
10.4.3.2. Regulatory Framework
10.4.3.3. Competitive Scenario
10.4.3.4. China Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.4. India
10.4.4.1. Key Country Dynamics
10.4.4.2. Regulatory Framework
10.4.4.3. Competitive Scenario
10.4.4.4. India Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.5. Australia
10.4.5.1. Key Country Dynamics
10.4.5.2. Regulatory Framework
10.4.5.3. Competitive Scenario
10.4.5.4. Australia Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.6. Thailand
10.4.6.1. Key Country Dynamics
10.4.6.2. Regulatory Framework
10.4.6.3. Competitive Scenario
10.4.6.4. Thailand Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.7. South Korea
10.4.7.1. Key Country Dynamics
10.4.7.2. Regulatory Framework
10.4.7.3. Competitive Scenario
10.4.7.4. South Korea Research Antibodies Market, 2021 - 2033 (USD Million)
10.4.8. Singapore
10.4.8.1. Key Country Dynamics
10.4.8.2. Regulatory Framework
10.4.8.3. Competitive Scenario
10.4.8.4. Singapore Research Antibodies Market, 2021 - 2033 (USD Million)
10.5. Latin America
10.5.1. Latin America Research Antibodies Market, 2021 - 2033 (USD Million)
10.5.2. Brazil
10.5.2.1. Key Country Dynamics
10.5.2.2. Regulatory Framework
10.5.2.3. Competitive Scenario
10.5.2.4. Brazil Research Antibodies Market, 2021 - 2033 (USD Million)
10.5.3. Argentina
10.5.3.1. Key Country Dynamics
10.5.3.2. Regulatory Framework
10.5.3.3. Competitive Scenario
10.5.3.4. Argentina Research Antibodies Market, 2021 - 2033 (USD Million)
10.6. MEA
10.6.1. MEA Research Antibodies Market, 2021 - 2033 (USD Million)
10.6.2. South Africa
10.6.2.1. Key Country Dynamics
10.6.2.2. Regulatory Framework
10.6.2.3. Competitive Scenario
10.6.2.4. South Africa Research Antibodies Market, 2021 - 2033 (USD Million)
10.6.3. Saudi Arabia
10.6.3.1. Key Country Dynamics
10.6.3.2. Regulatory Framework
10.6.3.3. Competitive Scenario
10.6.3.4. Saudi Arabia Research Antibodies Market, 2021 - 2033 (USD Million)
10.6.4. UAE
10.6.4.1. Key Country Dynamics
10.6.4.2. Regulatory Framework
10.6.4.3. Competitive Scenario
10.6.4.4. UAE Research Antibodies Market, 2021 - 2033 (USD Million)
10.6.5. Kuwait
10.6.5.1. Key Country Dynamics
10.6.5.2. Regulatory Framework
10.6.5.3. Competitive Scenario
10.6.5.4. Kuwait Research Antibodies Market, 2021 - 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Company Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2024
11.4. Company Profiles/Listing
11.4.1. Abcam Plc
11.4.1.1. Overview
11.4.1.2. Financial Performance
11.4.1.3. Product Benchmarking
11.4.1.4. Strategic Initiatives
11.4.2. Merck KGaA
11.4.2.1. Overview
11.4.2.2. Financial Performance
11.4.2.3. Product Benchmarking
11.4.2.4. Strategic Initiatives
11.4.3. Thermo Fisher Scientific, Inc.
11.4.3.1. Overview
11.4.3.2. Financial Performance
11.4.3.3. Product Benchmarking
11.4.3.4. Strategic Initiatives
11.4.4. Cell Signaling Technology, Inc.
11.4.4.1. Overview
11.4.4.2. Financial Performance
11.4.4.3. Product Benchmarking
11.4.4.4. Strategic Initiatives
11.4.5. Santa Cruz Biotechnology Inc.
11.4.5.1. Overview
11.4.5.2. Financial Performance
11.4.5.3. Product Benchmarking
11.4.5.4. Strategic Initiatives
11.4.6. PerkinElmer, Inc.
11.4.6.1. Overview
11.4.6.2. Financial Performance
11.4.6.3. Product Benchmarking
11.4.6.4. Strategic Initiatives
11.4.7. Becton, Dickinson and Company
11.4.7.1. Overview
11.4.7.2. Financial Performance
11.4.7.3. Product Benchmarking
11.4.7.4. Strategic Initiatives
11.4.8. Bio-Techne Corporation
11.4.8.1. Overview
11.4.8.2. Financial Performance
11.4.8.3. Product Benchmarking
11.4.8.4. Strategic Initiatives
11.4.9. Proteintech Group, Inc.
11.4.9.1. Overview
11.4.9.2. Financial Performance
11.4.9.3. Product Benchmarking
11.4.9.4. Strategic Initiatives
11.4.10. Jackson ImmunoResearch Inc
11.4.10.1. Overview
11.4.10.2. Financial Performance
11.4.10.3. Product Benchmarking
11.4.10.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us